Don’t let the cost of dry eye treatment force you to choose between comfortable vision
and your finances. We help eligible patients access Lacrisert for as little as $69.95 per
month through manufacturer Patient Assistance Programs.
The Lacrisert Prescription Assistance Program is a manufacturer-sponsored initiative that provides Lacrisert at no medication cost to qualifying patients who cannot afford it. The program is available to U.S. citizens and legal residents who have experienced financial or insurance hardships. The program provides up to one package of medication per request.
Moderate-to-severe dry eye syndrome is far more than a minor inconvenience — it’s a chronic condition causing constant burning, stinging, grittiness, light sensitivity, and blurred vision that can make reading, driving, or even keeping your eyes open painful. When artificial tears alone aren’t enough and a 2-month supply of Lacrisert costs $595+, the financial barrier feels insurmountable.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$620.00 | Save ~$550.05/mo |
| CVS Pharmacy | ~$595.00 | Save ~$525.05/mo |
| Walmart | ~$600.00 | Save ~$530.05/mo |
| Costco | ~$600.00 | Save ~$530.05/mo |
| Kroger | ~$610.00 | Save ~$540.05/mo |
*Retail prices are estimates based on public data and vary by pharmacy. Coupon prices from GoodRx and SingleCare as of April 2026. Afford My Prescriptions Advocacy Service bypasses retail pricing by using drug manufacturer programs to secure your medication for you—independent of dosage or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides medication at no cost if approved. But the process involves detailed applications, prescriber coordination, documentation, and ongoing management. Our $69.95/month covers full advocacy: applications, doctor coordination, documentation, refill management, and re-enrollment — so you focus on your health, not paperwork.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through Afford My Prescriptions is the better long-term solution:
Eligibility is generally determined by annual household income levels. Most programs follow guidelines that include a limit of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because these requirements can vary, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for assistance.
Lacrisert (hydroxypropyl cellulose ophthalmic insert) is a prescription dry eye treatment for adults with moderate-to-severe dry eye syndromes, including keratoconjunctivitis sicca. Unlike eye drops that wash away within minutes, Lacrisert is a tiny translucent rod-shaped insert (approximately 1.27 mm wide by 3.5 mm long) placed once daily into the pocket between your lower eyelid and eyeball. The insert slowly dissolves over 14–18 hours, continuously stabilizing your tear film. Each package contains 60 inserts, two reusable applicators, and illustrated instructions.
How It Works:
Lacrisert is a tiny, preservative-free rod that provides a sustained source of tear film support to combat dry eye syndrome. Once placed in the lower eyelid pocket, it slowly dissolves over 14–18 hours by absorbing fluid from existing tears. This process thickens and stabilizes the tear film, extending the time it stays intact and protected. Unlike standard eye drops, it offers a continuous layer of lubrication from just a single daily application.
Form and Use:
The medication is administered once daily, usually in the morning, using a special applicator to place the insert between the lower eyelid and eyeball. To help the insert soften more quickly, users can add one or two drops of artificial tears immediately after placement. Each package is supplied with 60 inserts and two reusable applicators. Detailed illustrated instructions are provided to ensure proper technique and placement.
Generic Availability:
As of April 2026, there is no generic version of the Lacrisert hydroxypropyl cellulose ophthalmic insert available in the United States. Its unique sustained-release design currently has no direct generic equivalent on the market. While other prescription treatments like Restasis, Xiidra, or Miebo are available for dry eye, they utilize entirely different medicinal pathways and are also brand-name products.
Warnings:
Users must remove contact lenses before applying the insert to the eye. It is common to experience temporary blurring of vision after application, so caution is advised. If any eye pain, persistent redness, or significant changes in vision occur, you should contact an eye doctor immediately. Additionally, this product should not be used by individuals who are hypersensitive to hydroxypropyl cellulose.
Lacrisert costs approximately $595–$700+ for a package of 60 inserts (a 2-month supply). The manufacturer copay card offers as little as $25 at participating pharmacies for commercially insured patients. Through AffordMyPrescriptions, qualifying patients receive Lacrisert at no medication cost — our $69.95 monthly fee covers advocacy and program management.
Yes. Lacrisert obtained through the Patient Assistance Program is the same FDA-approved ophthalmic insert manufactured by the same company that you would receive at any pharmacy.
No. As of April 2026, no generic hydroxypropyl cellulose ophthalmic insert is available in the United States. The unique sustained-release insert formulation has no direct generic equivalent.
Artificial tear drops provide momentary relief but wash away within minutes, requiring re- application 4–8+ times daily. Lacrisert is placed once daily and dissolves slowly over 14–18 hours, providing continuous tear film stabilization throughout the day. It’s designed for patients whose dry eye is too severe for drops alone.
Our Patient Advocates immediately explore every alternative — including the manufacturer’s $25 copay savings card (commercially insured), discounted uninsured pricing, GoodRx coupons, OTC preservative-free artificial tears as a lower-cost supplement, prescription anti-inflammatory dry eye treatments (Restasis, Xiidra) with their own PAPs, and insurance formulary exception requests with documentation of artificial tear failure.
Approval typically takes 2–4 weeks. Our advocates expedite the process by preparing complete applications, coordinating with your ophthalmologist, and proactively following up on your case.
If you are struggling with the high cost of Lacrisert, our team may be able to help you
access assistance programs designed to make medications more affordable. Check
your eligibility today and take the first step toward reducing your prescription costs.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.